Breaking News Instant updates and real-time market news.

AXP

American Express

, MA

MasterCard

09:25
01/12/17
01/12
09:25
01/12/17
09:25

CLSA financial tech analyst holds an analyst/industry conference call

Financial Tech Analyst McCrohan hosts Steve Mott, Principal at BetterBuyDesign, who discusses EMV (the Europay, Mastercard, Visa standard) and its prospects at the point of sale in 2017 on an Analyst/Industry conference call to be held on January 12 at 10:30 am.

AXP

American Express

MA

MasterCard

V

Visa

  • 12

    Jan

  • 19

    Jan

  • 31

    Jan

  • 02

    Feb

AXP American Express

01/09/17
01/09/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. American Express (AXP) upgraded to Buy from Neutral at BofA/Merrill with analyst Kenneth Bruce saying increased travel and entertainment spending and easing competitive concerns should drive a higher multiple. 2. Dr Pepper Snapple (DPS) upgraded to Neutral from Sell at Goldman with analyst Jason English saying potentially rising rates are a headwind to valuation, expects fundamentals to remain challenged on sluggish end market demand and big brand share challenges, and incremental headwinds from the rising U.S. dollar. 3. Clorox (CLX) upgraded to Equal Weight from Underweight at Barclays with analyst Lauren Lieberman upgrading Clorox to Equal Weight after lowering her U.S. Non-Food Consumer Staples sector view to Neutral from Positive. The analyst lowered her price target for the shares to $111 from $115. 4. JD.com (JD) upgraded to Overweight from Neutral at JPMorgan with analyst Alex Yao citing first-party revenue growth momentum and expectations for a third-party growth recovery in 2017. 5. Cummins (CMI) upgraded to Equal Weight from Underweight at Barclays with analyst Robert Wertheimer saying the company's , share loss may moderate while its capital deployment could drive upside. The analyst raised his price target for the shares to $135 from $108. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/17
OPCO
01/10/17
UPGRADE
Target $98
OPCO
Outperform
American Express upgraded to Outperform from Perform at Oppenheimer
Oppenheimer analyst Ben Chittenden upgraded American Express to Outperform citing a better economic backdrop and the stock's underperformance relative to peers since the U.S. election. A "good deal of the structural headwinds is priced into the multiple" at current valuation levels, Chittenden tells investors in a research note. He set a $98 price target for the shares.
01/10/17
01/10/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. American Express (AXP) upgraded to Outperform from Perform at Oppenheimer with analyst Ben Chittenden citing a better economic backdrop and the stock's underperformance relative to peers since the U.S. election. 2. Barracuda (CUDA) was upgraded to Neutral from Underperform at DA Davidson and to Overweight from Equal Weight at Stephens. 3. Acuity Brands (AYI) was upgraded to Outperform from Neutral at Baird and to Buy from Outperform at CLSA. 4. E-Trade (ETFC) upgraded to Buy from Neutral at Goldman with analyst Conor Fitzgerald saying he expects revenue acceleration from higher rates combined with balance sheet growth from deposit sweeps, focus on expenses by new management, and potential for reduced bank regulation. 5. Time Inc. (TIME) upgraded to Outperform from Market Perform at Wells Fargo with analyst Eric Katz citing potential upside from a takeover by Meredith (MDP). A combination makes sense, and Meredith shares are pricing in a $23 purchase price for Time, Katz tells investors in a research note. Should a deal not materialize, Time shares could fall to $14, but it's more likely a deal is done at $23 per share, the analyst argues. Katz raised his price target range for Time to $21-$23 from $15-$17. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/09/17
BOFA
01/09/17
UPGRADE
Target $90
BOFA
Buy
American Express upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Kenneth Bruce upgraded American Express to Buy and raised its price target to $90 from $77 saying increased travel and entertainment spending and easing competitive concerns should drive a higher multiple. Bruce said the election has increased corporate and consumer optimism that is driving better travel and entertainment spending and recent steps by Chase to roll-back aggressive incentives in its Sapphire Reserve program should reduce competitive concerns.
MA MasterCard

01/11/17
BARD
01/11/17
NO CHANGE
BARD
Outperform
PayPal partnerships should help protect margins, says Baird
After PayPal (PYPL) announced an expanded partnership with Discover Financial Services (DFS), Baird analyst Colin Sebastian said this latest deal "closely mirrors" the company's recently-signed Visa (V) and MasterCard (MA) partnerships, all of which he contends should help protect PayPal's margin profile. The analyst, who added that the early results from the company's customer choice expansion "look promising," keeps an Outperform rating on PayPal shares.
01/06/17
BMOC
01/06/17
NO CHANGE
BMOC
Outperform
Visa recent weakness offers good entry point, says BMO Capital
BMO Capital analyst Paulo Ribeiro named Visa (V) as his top pick in the Financial Technology sector and argued that the recent weakness offers a good entry point with a better set-up seen in FY17 for Visa compared to rival MasterCard (MA). To support the preference, Ribeiro called out a first full year of the Costco and USAA portfolios, easier year-over-year comparisons and accretion from its Visa Europe acquisition. Ribeiro rates Visa an Outperform with a $99 price target, while he has an Outperform rating and $123 price target on Mastercard shares.
01/05/17
01/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. MasterCard (MA) upgraded to Top Pick from Outperform at RBC Capital with analyst Daniel Perlin saying the company will benefit from improvements in the global economy, along with accelerating revenue growth, its recent acquisition of VocaLink, inflation, and new technological innovations. 2. Etsy (ETSY) upgraded to Buy from Hold at Loop Capital with analyst Blake Harper saying the company has done something most other retailers have not - fend off competition from Amazon (AMZN). The analyst does not expect Amazon to attract a meaningful share of Etsy shops and products. He raised his price target for Etsy shares to $16 from $14. 3. Chipotle (CMG) upgraded to Neutral from Underperform at Wedbush. 4. Progressive (PGR) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Kai Pan expecting core margins to inflect in 2017 due to a moderation in new business "drag," easier commercial auto comps in the second half of 2017, and sees additional upside from a lower tax rate and rising yield. 5. Southwest (LUV) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Rajeev Lalwani citing its Domestic exposure and defensive positioning. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/05/17
RBCM
01/05/17
UPGRADE
RBCM
Top Pick
MasterCard upgraded on multiple catalysts at RBC Capital
As noted earlier, RBC Capital upgraded MasterCard to Top Pick from Outperform. Analyst Daniel Perlin says that the company will benefit from improvements in the global economy, along with accelerating revenue growth, its recent acquisition of VocaLink, inflation, and new technological innovations. Target to $130 from $115.
V Visa

12/15/16
BOFA
12/15/16
UPGRADE
Target $92
BOFA
Buy
Visa upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Kenneth Bruce upgraded Visa to Buy from Neutral and raised its price target to $92 from $85 to reflect a healthier macro environment and potentially lower taxes and easing regulation that could drive earnings upside. Bruce said Visa's valuation has been pressured over the past few months due to a rotation into cyclical stocks and believes shares are well positioned to for a positive turn in sentiment in 2017.
12/16/16
STFL
12/16/16
NO CHANGE
STFL
Buying opportunity seen in Visa, MasterCard at Stifel
Stifel analyst Christopher Brendler believes that a buying opportunity has been created in Visa (V) and MasterCard (MA), as both stocks have "increasingly attractive relative valuations" and a "positive near-term fundamental outlook," according to Brendler. The analyst notes that Visa's stock is down 4% and MasterCard's is down 1.3% since the election. The analyst says that there is almost no possibility of the Trump Administration increasing the regulation of the credit card networks, and he expects both companies to benefit from domestic fiscal stimulus and a cash repatriation holiday. He keeps Buy ratings on both names but prefers Visa "on relative valuation and pricing upside from Visa Europe."

TODAY'S FREE FLY STORIES

VSM

Versum Materials

$37.86

0.16 (0.42%)

16:17
09/20/17
09/20
16:17
09/20/17
16:17
Initiation
Versum Materials initiated  »

Versum Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

16:17
09/20/17
09/20
16:17
09/20/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
09/20/17
09/20
16:16
09/20/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$45.21

1.41 (3.22%)

16:16
09/20/17
09/20
16:16
09/20/17
16:16
Syndicate
Juno Therapeutics files $225M automatic stock shelf »

Morgan Stanley and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$156.07

-2.66 (-1.68%)

, BSTI

Best Inc.

16:16
09/20/17
09/20
16:16
09/20/17
16:16
General news
On The Fly: Top stock stories for Wednesday »

Stocks were largely on…

AAPL

Apple

$156.07

-2.66 (-1.68%)

BSTI

Best Inc.

BABA

Alibaba

$177.95

-2.12 (-1.18%)

FDX

FedEx

$220.53

4.531 (2.10%)

ADBE

Adobe

$149.96

-6.64 (-4.24%)

GIS

General Mills

$52.17

-3.215 (-5.81%)

CPRT

Copart

$33.86

1.32 (4.06%)

ALNY

Alnylam

$113.78

38.7408 (51.63%)

IONS

Ionis Pharmaceuticals

$53.88

-5.19 (-8.79%)

BBBY

Bed Bath & Beyond

$22.74

-4.29 (-15.87%)

DESP

Despegar.com

CELC

Celcuity

$14.29

14.289 (1,428,900.00%)

ZLAB

Zai Lab

KRYS

Krystal Biotech

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 21

    Sep

  • 25

    Sep

  • 22

    Oct

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

APC

Anadarko

$44.78

1.02 (2.33%)

16:15
09/20/17
09/20
16:15
09/20/17
16:15
Hot Stocks
Anadarko reaffirms production guidance »

"Separately, we want…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

FCPT

Four Corners Property Trust

$25.32

0.02 (0.08%)

16:14
09/20/17
09/20
16:14
09/20/17
16:14
Hot Stocks
Four Corners Property Trust acquires 41 restaurant properties »

Four Corners Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$44.79

1.03 (2.35%)

16:13
09/20/17
09/20
16:13
09/20/17
16:13
Hot Stocks
Anadarko targets $1B of of share repurchases prior to year-end 2017 »

Speaking about the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

TBPH

Theravance Biopharma

$33.07

0.49 (1.50%)

, GSK

GlaxoSmithKline

$40.17

0.25 (0.63%)

16:12
09/20/17
09/20
16:12
09/20/17
16:12
Hot Stocks
GlaxoSmithKline and Innoviva report positive Phase 3 results of Treleg Ellipta »

Theravance Biopharma…

TBPH

Theravance Biopharma

$33.07

0.49 (1.50%)

GSK

GlaxoSmithKline

$40.17

0.25 (0.63%)

INVA

Innoviva

$13.59

0.08 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 24

    Oct

APC

Anadarko

$44.79

1.025 (2.34%)

16:11
09/20/17
09/20
16:11
09/20/17
16:11
Hot Stocks
Anadarko announces $2.5B share repurchase program »

Anadarko Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

QUAD

Quad/Graphics

$20.16

0.33 (1.66%)

16:11
09/20/17
09/20
16:11
09/20/17
16:11
Hot Stocks
Quad/Graphics awarded $450M contract to print all Bluestem catalogs »

Quad/Graphics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

MLHR

Herman Miller

16:11
09/20/17
09/20
16:11
09/20/17
16:11
Hot Stocks
Breaking Hot Stocks news story on Herman Miller »

Herman Miller reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

STBZ

State Bank Financial

$27.79

0.45 (1.65%)

16:08
09/20/17
09/20
16:08
09/20/17
16:08
Hot Stocks
FDIC approves State Bank Financial, AloStar merger transaction »

State Bank Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

16:07
09/20/17
09/20
16:07
09/20/17
16:07
Hot Stocks
Herman Miller CEO says 'encouraged by the strong level of demand' »

Brian Walker, CEO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

ARCC

Ares Capital

$15.85

0.035 (0.22%)

16:07
09/20/17
09/20
16:07
09/20/17
16:07
Initiation
Ares Capital initiated  »

Ares Capital initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

16:06
09/20/17
09/20
16:06
09/20/17
16:06
Earnings
Herman Miller sees Q2 EPS 55c-61c, consensus 56c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

MLHR

Herman Miller

16:05
09/20/17
09/20
16:05
09/20/17
16:05
Earnings
Herman Miller reports Q1 adjusted EPS 57c, consensus 57c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

MDXG

MiMedx

$12.34

-0.82 (-6.23%)

16:05
09/20/17
09/20
16:05
09/20/17
16:05
Hot Stocks
MiMedx responds to two "deceptive short seller articles" »

MiMedx Group responded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

LUNA

Luna Innovations

$1.64

0.05 (3.14%)

16:05
09/20/17
09/20
16:05
09/20/17
16:05
Hot Stocks
Luna Innovations announces stock repurchase program »

Luna Innovations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$53.40

-5.2 (-8.87%)

16:03
09/20/17
09/20
16:03
09/20/17
16:03
Hot Stocks
Aerie announces FDA Advisory Committee meeting for Rhopressa 0.02% »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 28

    Feb

AMD

AMD

$13.12

0.04 (0.31%)

, TSLA

Tesla

$375.10

-9.9 (-2.57%)

15:57
09/20/17
09/20
15:57
09/20/17
15:57
Periodicals
Tesla working with AMD on self-driving car AI chip, CNBC says »

Tesla (TSLA) is using AMD…

AMD

AMD

$13.12

0.04 (0.31%)

TSLA

Tesla

$375.10

-9.9 (-2.57%)

NVDA

Nvidia

$187.35

-0.2 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

AMD

AMD

$13.12

0.04 (0.31%)

, TSLA

Tesla

$375.10

-9.9 (-2.57%)

15:54
09/20/17
09/20
15:54
09/20/17
15:54
Periodicals
Breaking Periodicals news story on AMD, Tesla »

Tesla working with AMD on…

AMD

AMD

$13.12

0.04 (0.31%)

TSLA

Tesla

$375.10

-9.9 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

15:50
09/20/17
09/20
15:50
09/20/17
15:50
General news
More from Yellen: »

More from Yellen: FOMC…

VIX

Volatility Index S&P 500 Options

15:40
09/20/17
09/20
15:40
09/20/17
15:40
Options
Active trading in VIX calls as players replace expiring positions »

Active trading in VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:35
09/20/17
09/20
15:35
09/20/17
15:35
General news
Yellen on the FRB »

Yellen on the FRB: she is…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.